《Respir Invest,6月28日,Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-06-29
  • Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020

    Author links open overlay panelToshieManabeaHiroyasuAkatsubKazuhikoKotaniaKoichiroKudocd

    Show more

    https://doi.org/10.1016/j.resinv.2020.05.005

    Abstract

    Background

    Since novel coronavirus disease (COVID-19) emerged, various clinical features of COVID-19 have been reported.

    Methods

    We conducted a systematic review of published studies reporting the clinical features of COVID-19. Two investigators independently searched PubMed (December 2019–February 2020) for eligible articles. A meta-analysis was performed to measure the frequencies of clinical outcomes and symptoms of COVID-19. A stratified analysis was conducted according to the timeline of outbreak and exposure histories: Group I, most patients were exposed to the Hunan seafood wholesale market and lived in Wuhan, Hubei province; Group II, patients lived in Hubei province but were not directly exposed to the market; and Group III, patients lived outside Hubei.

  • 原文来源:https://www.sciencedirect.com/science/article/pii/S2212534520300897
相关报告
  • 《TMID,3月13日,Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-16
    • Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis Alfonso J.Rodriguez-Morales, Jaime A.Cardona-Ospina, EstefaníaGutiérrez-Ocampo, RhuviVillamizar-Peña, YeimerHolguin-Rivera, Juan PabloEscalera-Antezana, Lucia ElenaAlvarado-Arnez, D. KatterineBonilla-Aldana, CarlosFranco-Paredes, Andrés F.Henao-Martinez, AlbertoPaniz-Mondolfi, Guillermo J.Lagos-Grisales, EduardoRamírez-Vallejo, Jose A.Suárez, Lysien I.Zambrano, Wilmer E.Villamil-Gómez, Graciela J.Balbin-Ramon, Ali A.Rabaan, …RanjitSah Show more https://doi.org/10.1016/j.tmaid.2020.101623 Abstract Introduction An epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 in China leading to a Public Health Emergency of International Concern (PHEIC). Clinical, laboratory, and imaging features have been partially characterized in some observational studies. No systematic reviews on COVID-19 have been published to date.
  • 《MCP,6月6日,Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-07
    • Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis Author links open overlay panelAkosua AdomAgyemanBPharm, MSc1KenLee ChinBPharm (Hons), MClinPharm, PhD23Cornelia B.LandersdorferBPharm, PhD1DannyLiewMBBS (Hons), BMedSc, FRACP, PhD2RichardOfori-AsensoBPharm, MSc, PhD24 https://doi.org/10.1016/j.mayocp.2020.05.030 Abstract Objective To estimate the prevalence of olfactory and gustatory dysfunctions (OGDs) among patients infected with novel coronavirus disease 2019 (COVID-19). Patients and Methods A systematic review was conducted by searching MEDLINE, EMBASE, and the preprint server MedRxiv until 11 May 2020 using the terms ‘anosmia’ or ‘hyposmia’ or ‘dysosmia’ or ‘olfactory dysfunction’ or ‘olfaction disorder’ or ‘smell dysfunction’ or ‘ageusia’ or ‘hypogeusia’ or ‘dysgeusia’ or ‘taste dysfunction’ or ‘gustatory dysfunction’ or ‘neurological’ and ‘COVID-19’ or ‘2019 novel coronavirus’ or ‘2019-nCoV’ or ‘SARS-CoV-2’. References of included studies were also manually screened. Only studies involving diagnostic-confirmed patients with COVID-19 were included. Random-effects meta-analysis was performed.